Order Article Reprints

Asaftei SD, Puma N, Paioli A, Petraz M, Morosi C, Podda M, Tamburini A, Palmerini E, Coccoli L, Grignani G, et al. Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. Cancers. 2021; 13(12):3046. https://doi.org/10.3390/cancers13123046

Asaftei, Sebastian Dorin, Nadia Puma, Anna Paioli, Marco Petraz, Carlo Morosi, Marta Podda, Angela Tamburini, Emanuela Palmerini, Luca Coccoli, Giovanni Grignani, and et al. 2021. "Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study" Cancers 13, no. 12: 3046. https://doi.org/10.3390/cancers13123046

Asaftei, S. D., Puma, N., Paioli, A., Petraz, M., Morosi, C., Podda, M., Tamburini, A., Palmerini, E., Coccoli, L., Grignani, G., Manzitti, C., Bertulli, R., De Leonardis, F., Rabusin, M., Campello, A., Tirtei, E., Picci, P., Prete, A., Longhi, A., ... Luksch, R. (2021). Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. Cancers, 13(12), 3046. https://doi.org/10.3390/cancers13123046